Great Novel Therapeutics Biotech & Medicals (TPEX:7427)
Taiwan
· Delayed Price · Currency is TWD 32.50
+0.85 (2.69%)
Mar 10, 2026, 1:59 PM CST
TPEX:7427 Market Cap
TPEX:7427 has a market cap or net worth of 1.36 billion as of March 9, 2026. Its market cap has decreased by -25.21% in one year.
Market Cap
1.36B
Enterprise Value
867.76M
Revenue
1.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
32.50
Market Cap Chart
Since July 8, 2021, TPEX:7427's market cap has decreased from 1.48B to 1.36B, a decrease of -8.06%. That is a compound annual growth rate of -1.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 1.36B | -1.09% |
| Dec 31, 2025 | 1.37B | -7.37% |
| Dec 31, 2024 | 1.48B | -42.09% |
| Dec 29, 2023 | 2.56B | 40.55% |
| Dec 30, 2022 | 1.82B | 94.83% |
| Dec 30, 2021 | 935.73M | -36.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Meribank Biotech | 1.45B |
| Abnova (Taiwan) | 1.47B |
| NeoCore Technology | 1.50B |
| GenMont Biotech Incorporation | 1.54B |
| Enimmune | 1.27B |
| GeneReach Biotechnology | 1.17B |
| Genomics BioSci & Tech. | 1.75B |
| Lukas Biomedical | 1.12B |